title: The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human alpha1A1-adrenoceptors.
abstract: Antipsychotic drugs often cause orthostatic hypotension, probably through antagonist action on resistance vessel alpha(1A)-adrenoceptors. Here we have tested this possibility directly using cells transfected with a relevant human alpha(1A)-adrenoceptor splice variant. To determine a splice variant which was relevant, we used quantitative real-time polymerase chain reaction (qPCR) to determine the prevalence in human subcutaneous small arteries of three of the five splice variants ADRA1A_v1-5, which encode functional protein: alpha(1A1)-, alpha(1A3)-, alpha(1A4)-adrenoceptors. Our statistical analysis showed higher transcription levels of alpha(1A1)- than of alpha(1A3)- and alpha(1A4)-adrenoceptors (1.6 and 5.8 times, respectively). We therefore chose to study the alpha(1A1)-adrenoceptor, and the cDNA encoding it was transfected into the Flp-In-293 (modified from HEK-293) cell line to produce a cell line stably expressing a functional form of this splice variant. The expression of recombinant alpha(1A1)-adrenoceptor subtype was confirmed by Western immunoblot analysis, and its functionality demonstrated using a Fura-2 assay by a rise in intracellular calcium concentration ([Ca(2+)](i)) when challenged with phenylephrine (EC(50)=1.61x10(-8) M). From Schild analysis, prazosin, sertindole, risperidone, and haloperidol caused a concentration-dependent, rightward shift of the cumulative concentration-response curves for phenylephrine in cells expressing human recombinant alpha(1A1)-adrenoceptors to yield pK(B) values of 8.40, 8.05, 8.26 and 7.38, respectively. In [7-methoxy-(3)H]-prazosin binding experiments, high expression was seen (B(max)=48.5+/-16.7 pmol/mg protein, +/-S.E.M.) along with high affinity binding to a single site (K(d)=0.210+/-0.034 nM). The pharmacological profiles of recombinant human alpha(1A1)-adrenoceptors in competition binding studies confirmed much higher antagonist affinity of sertindole and risperidone than haloperidol for these receptors. In summary, it can be concluded that there is an approximately 10-fold higher adrenoceptor affinity of risperidone and sertindole for human alpha(1A1)-adrenoceptors compared to haloperidol. These findings are consistent with the observation that risperidone and sertindole have a higher incidence of orthostatic hypotension than haloperidol.
authors.affiliation: Department of Pharmacology, University of Aarhus, Aarhus, Denmark.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Nourian
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mulvany
authors.forename: Karsten Bork
authors.initials: KB
authors.lastname: Nielsen
authors.forename: Darryl S
authors.initials: DS
authors.lastname: Pickering
authors.forename: Torsten
authors.initials: T
authors.lastname: Kristensen
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001158:Arteries / Q000378:metabolism; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D006220:Haloperidol / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology; D007211:Indoles / Q000009:adverse effects / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D020033:Protein Isoforms / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D011869:Radioligand Assay; D018340:Receptors, Adrenergic, alpha-1 / Q000096:biosynthesis / Q000235:genetics; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D018967:Risperidone / Q000009:adverse effects / Q000494:pharmacology; D012867:Skin / Q000098:blood supply; D014316:Tritium; D014655:Vascular Resistance
chemical_list: C547713:ADRA1A protein, human; D058668:Adrenergic alpha-1 Receptor Antagonists; D014150:Antipsychotic Agents; D007093:Imidazoles; D007211:Indoles; D020033:Protein Isoforms; D018340:Receptors, Adrenergic, alpha-1; D011994:Recombinant Proteins; D014316:Tritium; D010656:Phenylephrine; C066304:sertindole; D006220:Haloperidol; D018967:Risperidone; D002118:Calcium; D011224:Prazosin